An overview of cytokine interactions in atherosclerosis and implications for peripheral arterial disease. (Q37019592)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18048466 AND SRC:MED&resulttype=core&format=json

28 December 2019

review article

1 reference

title

An overview of cytokine interactions in atherosclerosis and implications for peripheral arterial disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18048466 AND SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18048466 AND SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Girn HR

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18048466 AND SRC:MED&resulttype=core&format=json

28 December 2019

Homer-Vanniasinkam S

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18048466 AND SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 November 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18048466 AND SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18048466 AND SRC:MED&resulttype=core&format=json

28 December 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18048466 AND SRC:MED&resulttype=core&format=json

28 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18048466 AND SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

299-309

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18048466 AND SRC:MED&resulttype=core&format=json

Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000.

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Peripheral arterial disease detection, awareness, and treatment in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Presidential address: a team for the 21st century: the vascular center

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

T(H)2 predominant immune responses prevail in human abdominal aortic aneurysm

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Patterns of inflammation associated with peripheral arterial disease: the InCHIANTI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Elevated interleukin-1beta in pericardial fluid of patients with ischemic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Chronic inflammation, immune response, and infection in abdominal aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

The roles for cytokines in the generation and maintenance of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Local cytokine environments drive aneurysm formation in allografted aortas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Cytokine production by dendritic cells genetically engineered to express IL-4: induction of Th2 responses and differential regulation of IL-12 and IL-23 synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

TH1/TH2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines--immunological alterations in acute coronary syndrome and stable coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Histone acetylase and deacetylase activity in alveolar macrophages and blood mononocytes in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

START Trial: a pilot study on STimulation of ARTeriogenesis using subcutaneous application of granulocyte-macrophage colony-stimulating factor as a new treatment for peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Granulocyte-macrophage colony-stimulating factor stimulates arteriogenesis in a pig model of peripheral artery disease using clinically applicable infusion pumps

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Stimulation of B-cell progenitors by cloned murine interleukin-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Cell biology of IL-7, a key lymphotrophin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Interleukin-7-mediated inflammation in unstable angina: possible role of chemokines and platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Multiplexed flow cytometric analyses of pro- and anti-inflammatory cytokines in the culture media of oxysterol-treated human monocytic cells and in the sera of atherosclerotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Markers of vascular inflammation are associated with the extent of atherosclerosis assessed as angiographic score and treadmill walking distances in patients with peripheral arterial occlusive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

The role of endothelial cell reactive antibodies in peripheral arterial disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Inflammatory markers and IL-6 polymorphism in peripheral arterial disease with and without diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Osteoprotegerin plasma concentrations correlate with severity of peripheral artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Cytokine signatures in atherosclerotic claudicants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Inflammatory status and endothelial function in asymptomatic and symptomatic peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

IL-6, TNF-alpha and atherosclerosis risk indicators in a healthy family population: the STANISLAS cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Interleukins in atherosclerosis: molecular pathways and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Interleukin 12 induces T-cell recruitment into the atherosclerotic plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

T helper cell related interleukins and the angiographic morphology in unstable angina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Statin inhibits interferon-gamma-induced expression of intercellular adhesion molecule-1 (ICAM-1) in vascular endothelial and smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Cytokines in atherosclerosis: pathogenic and regulatory pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Gamma interferon: a central mediator in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Interferon-gamma and atherosclerosis: pro- or anti-atherogenic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Detection and localization of tumor necrosis factor in human atheroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

TNF and congestive heart failure: therapeutic possibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Modulation of atherogenesis by chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

The role of chemokines in human cardiovascular pathology: enhanced biological insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Markers of inflammation and their clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Chemokines in the pathogenesis of vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Inflammatory Cytokines and Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Risk factor analysis of plasma cytokines in patients with coronary artery disease by a multiplexed fluorescent immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Intramuscular gene transfer of interleukin-10 cDNA reduces atherosclerosis in apolipoprotein E-knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Cytokine pattern in aneurysmal and occlusive disease of the aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Transforming growth factor-β and the protection from cardiovascular injury hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Transforming growth factor beta and atherosclerosis: so far, so good for the protective cytokine hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Effects of TGF-beta2 on immune response-related gene expression profiles in the human corneal endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Bidirectional regulation of macrophage function by TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

C-Reactive Protein, Interleukin-6, and Soluble Adhesion Molecules as Predictors of Progressive Peripheral Atherosclerosis in the General Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Interleukin-18/Interleukin-18 Binding Protein Signaling Modulates Atherosclerotic Lesion Development and Stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Expression of Interleukin-18 in Human Atherosclerotic Plaques and Relation to Plaque Instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Protective Role of Interleukin-10 in Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Expression of Interleukin-10 in Advanced Human Atherosclerotic Plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1358863X07083387

21 January 2018

Identifiers

DOI

10.1177/1358863X07083387

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18048466 AND SRC:MED&resulttype=core&format=json

28 December 2019

1 reference